Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,291
Views
13
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA PTAR inhibits apoptosis but promotes proliferation, invasion and migration of cervical cancer cells by binding miR-101

Xuehe Wanga Department of Gynaecology, Songshan Hospital of Qingdao University Medical College, QingdaoShandong, ChinaCorrespondence[email protected]
,
Huaqin Sunb Department of Gynaecology, The Affiliated Hospital of Qingdao University, QingdaoChina
&
Simin Zhub Department of Gynaecology, The Affiliated Hospital of Qingdao University, QingdaoChina
Pages 4536-4545 | Received 21 Apr 2021, Accepted 17 Jun 2021, Published online: 29 Jul 2021

References

  • Walker JL, Piedmonte MR, NM S, et al. Pearl ML and Sharma SK: recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: gynecologic Oncology Group LAP2 Study. J Clin Oncol. 2012;30(7):695–700.
  • Peng L, Peng W. Hu P and Zhang HF: clinical significance of expression levels of serum ADRA1A in hysterocarcinoma patients. Oncol Lett. 2018;15(6):9162–9166.
  • Calle AS, Kawamura Y, Yamamoto Y. Takeshita F and Ochiya T: emerging roles of long non‐codingRNAin cancer. Cancer Sci. 2018;109(7):2093–2100.
  • Paul P, Chakraborty A, Sarkar D, et al. Malakar AK and Chakraborty S. Interplay between miRNAs and Human Diseases: a Review. J Cell Physiol. 2007-2018, 2018;233: 2007–2018.
  • Shi X, Sun M, Liu H. Yao Y and Song Y: long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–166.
  • Guo X, Xiao H, Guo S, et al. Chen J and Lou G: long noncoding RNA HOTAIR knockdown inhibits autophagy and epithelial-mesenchymal transition through the Wnt signaling pathway in radioresistant human cervical cancer HeLa cells. J Cell Physiol. 2008;234(4):3478–3489.
  • Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17(1):1–13. .
  • Tan X, Banerjee P, Liu X, et al. The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest. 2018;128(4):1267–1282. .
  • Ratner ES, Tuck D, Richter C, et al. Putherford TJ and Weidhaas JB: microRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol. 2018;118(3):251–257.
  • Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci US A. 2009;106(28):11667–11672. .
  • Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9(6):703–719.
  • Song YX, Sun JX, Zhao JH, et al. Non-coding RNAs participate in the regulatory network of CLDN4 viaceRNA mediated miRNA evasion. Nat Commun. 2017;8:289: 1–17.
  • Chen D, Lu Y, Zhang J, et al. Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression. Theranostics. 2017;7(19):4836–4849.
  • Wu X, Wang F, Li H, et al. LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO Rep. 1837-1853, 2017;18: 1837–1853.
  • Zhao B, Yang Y, Hu LB, et al. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/Smad signaling pathway. Cancer Biomark. 2017;21(3):613–620. .
  • He X, Shao Y, Li X, et al. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J. 2012;279(22):4201–4212. .
  • Strillacci A, Griffoni C, Sansone P, et al. downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res. 2009;315(8):1439–1447. MiR-101. .
  • Hao Y, Gu X, Zhao Y, et al. Enforced Expression of miR-101 Inhibits Prostate Cancer Cell Growth by Modulating the COX-2 Pathway In Vivo. Cancer Prev Res. 2011;4(7):1073–1083.
  • Konno Y, Dong P, Xiong Y, et al. MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells. Oncotarget. 2015;51:S12–S12.
  • Han L, Chen W, Xia Y, et al. inhibits the proliferation and metastasis of lung cancer by targeting zinc finger E-box binding homeobox 1. Am J Transl Res. 2018;10(4): 1172–1183. MiR-101.
  • Li L, Shao MY, Zou SC, et al. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44. J Neurooncol 2019;141(1): 19–30

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.